Skip to main content

Clarithromycin Treatment of Helicobacter pylori and Chlamydia pneumoniae Infections Decreases Fibrinogen Plasma Level in Patients with Ischemic Heart Disease

  • Chapter
Book cover Chlamydia pneumoniae
  • 53 Accesses

Abstract

Recent data suggest that active inflammation and/or infection in the coronary arteries may play a role in ischemic heart disease (IHD) [1, 2]. The infectious theory has been suggested by epidemiological, serological, immunohistochemical and in situ hybridization studies, which indicated a possible etiologic role of some viruses and bacteria in the development of atherosclerotic lesions [3–5]. Among the micro-organisms potentially implicated, Chlamydia pneumoniae is the most extensively studied in the literature [6–9].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Nieminen MS, Mattila K, Valtonen V (1993) Infection and inflammation as a risk factor for myocardial infarction. Eur Heart J 14[Suppl K]: 12–16

    PubMed  Google Scholar 

  2. Alexander RW (1994) Inflammation and coronary artery disease. N Engl J Med 331: 468–469

    Article  PubMed  CAS  Google Scholar 

  3. Beneditt EP, Barret T, McDougall JK (1983) Viruses and etiology of atherosclerosis. Proc Natl Acad Sci USA 80: 6386–6389

    Article  Google Scholar 

  4. Pesonen E, Siitonen O (1981) Acute myocardial infarction precipitated by infectious diseases. Am Heart J 101: 512–513

    Article  PubMed  CAS  Google Scholar 

  5. Spodick DH, Flessas AP, Johnson MM (1984) Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 53: 481–482

    Article  PubMed  CAS  Google Scholar 

  6. Saikku P (1993) Chlamydia pneumoniae as a risk factor in acute myocardial infarction. Eur Heart J 14[Suppl K]: 62–65

    PubMed  Google Scholar 

  7. Saikku P, Leinonen M, Mattila K et al (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii: 983–986

    Article  Google Scholar 

  8. Shor A, Kuo C-C, Patton DL (1992) Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 82: 158–161

    PubMed  CAS  Google Scholar 

  9. Kuo C-C, Shor A, Campbell LA et al (1993) Demonstration of Chlamydia pneumoniaein atherosclerotic lesions of coronary arteries. J Infect Dis 167: 845–849

    Article  Google Scholar 

  10. Mendall MA, Goggin PM, Molineaux N et al (1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71: 437–439

    Article  PubMed  CAS  Google Scholar 

  11. Aceti A, Mazzacurati G, Amendola MA et al (1996) H. pylori and C. pneumoniae infections may account for most acute coronary syndrome. BMJ 313: 428–429

    Article  PubMed  CAS  Google Scholar 

  12. Morgando A, Sanseverino P, Perotto C et al (1995) Helicobacter pylori seropositivity in myocardial infarction. Lancet 345: 1380 (letter)

    PubMed  CAS  Google Scholar 

  13. Patel P, Carrington D, Strachan DP et al (1994) Fibrinogen: a link between chronic infection and coronary heart disease. Lancet 343: 1634–1635

    Article  PubMed  CAS  Google Scholar 

  14. Wald NJ, Law MR, Morris JK et al (1997) Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ 315: 1199–1201

    Article  PubMed  CAS  Google Scholar 

  15. Gupta S, Leatham EW, Carrington D et al (1997) Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96: 404–407

    PubMed  CAS  Google Scholar 

  16. Gurfinkel E, Bozovich G, Daroca A et al (1997) Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 350: 404–407

    Article  PubMed  CAS  Google Scholar 

  17. Agen C, Danesi R, Blandizzi C et al (1993) Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected role. Agents Actions 38:(1–2)85–90

    Article  PubMed  CAS  Google Scholar 

  18. Liuzzo G, Biasucci LM, Gallimore JR et al (1994) The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331: 417–424

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Italia, Milano

About this chapter

Cite this chapter

Allegra, L., Cosentini, R., Tarsia, P. (1999). Clarithromycin Treatment of Helicobacter pylori and Chlamydia pneumoniae Infections Decreases Fibrinogen Plasma Level in Patients with Ischemic Heart Disease. In: Allegra, L., Blasi, F. (eds) Chlamydia pneumoniae. Springer, Milano. https://doi.org/10.1007/978-88-470-2280-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2280-5_19

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0047-6

  • Online ISBN: 978-88-470-2280-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics